Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mimi I Hu

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Endocrinology and Metabolism Clinics of North America|November 14, 2021
Hypercalcemia of MalignancyMimi I Hu
Clinical Advances in Hematology & Oncology : H&O|June 21, 2011
Updates in the management of medullary thyroid cancerMimi I Hu
Future Oncology (London, England)|September 26, 2015
Denosumab: a new agent in the management of hypercalcemia of malignancySonali Thosani, Mimi I Hu
Annales D'Endocrinologie|February 11, 2024
RET kinase inhibitors for the treatment of RET-altered thyroid cancers: Current knowledge and future directionsSarah Hamidi, Mimi I Hu
Thyroid : Official Journal of the American Thyroid Association|May 2, 2012
Medullary thyroid carcinoma: who's on first?Mimi I Hu, Gilbert J Cote
Therapeutic Advances in Medical Oncology|June 27, 2022
RET kinase inhibitors for <i>RET</i>-altered thyroid cancersDanica M Vodopivec, Mimi I Hu
JCEM Case Reports|July 30, 2024
Paraneoplastic Diarrhea From Medullary Thyroid Carcinoma Resolved With Yttrium-90 Radioembolization of Liver MetastasesSarah Hamidi, Armeen Mahvash, Mimi I Hu
Current Opinion in Endocrinology, Diabetes, and Obesity|July 22, 2021
Medullary thyroid carcinomaTania Jaber, Ramona Dadu, Mimi I Hu
The Journal of Clinical Endocrinology and Metabolism|September 20, 2014
Medullary thyroid cancer in the era of tyrosine kinase inhibitors: to treat or not to treat--and with which drug--those are the questionsMaria E Cabanillas, Mimi I Hu, Camilo Jimenez
Current Rheumatology Reports|May 4, 2010
Cancer therapies and bone healthMimi I Hu, Huifang Lu, Robert F Gagel
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Endocrinology and Metabolism Clinics of North America|November 14, 2021
Hypercalcemia of MalignancyMimi I Hu
Clinical Advances in Hematology & Oncology : H&O|June 21, 2011
Updates in the management of medullary thyroid cancerMimi I Hu
Future Oncology (London, England)|September 26, 2015
Denosumab: a new agent in the management of hypercalcemia of malignancySonali Thosani, Mimi I Hu
Annales D'Endocrinologie|February 11, 2024
RET kinase inhibitors for the treatment of RET-altered thyroid cancers: Current knowledge and future directionsSarah Hamidi, Mimi I Hu
Thyroid : Official Journal of the American Thyroid Association|May 2, 2012
Medullary thyroid carcinoma: who's on first?Mimi I Hu, Gilbert J Cote
Therapeutic Advances in Medical Oncology|June 27, 2022
RET kinase inhibitors for <i>RET</i>-altered thyroid cancersDanica M Vodopivec, Mimi I Hu
JCEM Case Reports|July 30, 2024
Paraneoplastic Diarrhea From Medullary Thyroid Carcinoma Resolved With Yttrium-90 Radioembolization of Liver MetastasesSarah Hamidi, Armeen Mahvash, Mimi I Hu
Current Opinion in Endocrinology, Diabetes, and Obesity|July 22, 2021
Medullary thyroid carcinomaTania Jaber, Ramona Dadu, Mimi I Hu
The Journal of Clinical Endocrinology and Metabolism|September 20, 2014
Medullary thyroid cancer in the era of tyrosine kinase inhibitors: to treat or not to treat--and with which drug--those are the questionsMaria E Cabanillas, Mimi I Hu, Camilo Jimenez
Current Rheumatology Reports|May 4, 2010
Cancer therapies and bone healthMimi I Hu, Huifang Lu, Robert F Gagel
Pageof 10